Trials / Completed
CompletedNCT00469131
Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid
Randomized Comparative Study on Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparison Between Tacrolimus + MMF and Tacrolimus + Steroid
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare immunosuppression protocol of tacrolimus + MMF with that of tacrolimus + steroid for preventing recurrence of hepatitis C after living donor liver transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus + steroid | |
| DRUG | tacrolimus + mycophenolate mofetil |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2010-08-01
- Completion
- 2011-08-01
- First posted
- 2007-05-04
- Last updated
- 2011-09-14
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00469131. Inclusion in this directory is not an endorsement.